MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PAREXEL International Company Profile (NASDAQ:PRXL)

Consensus Ratings for PAREXEL International (NASDAQ:PRXL) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $69.94 (17.54% upside)

Analysts' Ratings History for PAREXEL International (NASDAQ:PRXL)
Show:
DateFirmActionRatingPrice TargetActions
6/27/2016Robert W. BairdReiterated RatingOutperform$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Credit SuisseInitiated CoverageOutperform$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016Jefferies GroupReiterated RatingHold$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Evercore ISIUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyBancReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Avondale PartnersLower Price TargetUnderperform$50.50 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016SunTrustUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Citigroup Inc.Reiterated RatingBuy$64.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/1/2015Deutsche BankReiterated RatingHold$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014BarclaysReiterated RatingOverweight$59.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Sterne Agee CRTBoost Price Target$36.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for PAREXEL International (NASDAQ:PRXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
4/27/2016Q316$0.90$0.89$523.16 million$527.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q2$0.72$0.90$523.03 million$518.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q116$0.63$0.70$511.77 million$512.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q415$0.74$0.79$527.13 million$523.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q315$0.66$0.66$513.50 million$502.03 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q215$0.60$0.69$502.20 million$499.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q115$0.58$0.65$505.60 million$491.69 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q414$0.62$0.65$508.99 million$510.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q314$0.54$0.56$493.35 million$492.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q214$0.49$0.49$479.49 million$487.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q114$0.45$0.45$458.94 million$449.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q4 2013$0.43$0.50$455.23 million$463.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q3 2013$0.40$0.50$438.10 million$454.49 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q2 2013$0.33$0.41$419.78 million$422.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012Q113$0.29$0.29$396.70 million$394.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012$0.31$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2012$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2011$0.15$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2011$0.07$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2011$0.30$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2011$0.28$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for PAREXEL International (NASDAQ:PRXL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.88$0.91$0.89
Q2 20166$0.96$1.07$1.02
Q3 20164$0.81$1.00$0.92
Q4 20165$0.91$1.08$0.95
Q1 20173$0.90$0.93$0.91
Q2 20173$0.96$0.98$0.97
Q3 20173$1.00$1.02$1.01
Q4 20173$1.01$1.07$1.04
(Data provided by Zacks Investment Research)
Dividend History for PAREXEL International (NASDAQ:PRXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for PAREXEL International (NASDAQ:PRXL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016A Dana Callow JrDirectorSell3,000$60.04$180,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Eduard E HoldenerDirectorSell700$62.98$44,086.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Ulf I SchneiderSVPSell7,500$62.00$465,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Ulf I SchneiderSVPSell6,000$61.00$366,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Ulf I SchneiderSVPSell6,000$60.01$360,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ulf I SchneiderSVPSell8,000$59.24$473,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2016Richard L LoveDirectorSell1,330$62.50$83,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Richard L LoveDirectorSell1,330$68.21$90,719.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Eduard E HoldenerDirectorSell2,200$67.66$148,852.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Gadi SaaronySVPSell12,425$67.01$832,599.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Patrick J FortuneDirectorSell1,500$68.07$102,105.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Richard L LoveDirectorSell1,330$64.26$85,465.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Mark A GoldbergCOOSell8,995$73.49$661,042.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Thomas SenderovitzSVPSell1,500$74.02$111,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015Mark A GoldbergCOOSell11,507$70.03$805,835.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Richard L LoveDirectorSell5,000$65.00$325,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Mark A GoldbergCOOSell12,884$68.99$888,867.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015A Dana Callow JrDirectorSell2,000$65.84$131,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Christopher J LindopDirectorSell2,000$63.59$127,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Rickenbach Josef H VonCEOSell65,100$62.53$4,070,703.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Eduard E HoldenerDirectorSell3,000$62.97$188,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Douglas A BattSVPSell8,300$60.89$505,387.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Gadi SaaronyVPSell8,525$60.97$519,769.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2014Mark A GoldbergCOOSell25,345$58.99$1,495,101.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Christopher J LindopDirectorSell12,000$55.00$660,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Gadi SaaronyVPSell6,075$57.78$351,013.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Anita CooperVPSell4,916$57.56$282,964.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Anita CooperVPSell5,084$57.50$292,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014Anita CooperVPSell6,800$57.54$391,272.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Mark A GoldbergCOOSell16,761$56.33$944,147.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Richard L LoveDirectorSell6,000$57.33$343,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Patrick J FortuneDirectorSell3,000$53.04$159,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Anita CooperVPSell2,500$53.00$132,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Mark GoldbergCOOSell11,206$52.49$588,202.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Mark GoldbergCOOSell12,199$50.49$615,927.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Anita CooperVPSell10,000$50.00$500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Eduard HoldenerDirectorSell6,000$49.62$297,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Rickenbach Josef VonCEOSell50,000$49.76$2,488,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Gadi SaaronyVPSell9,950$49.56$493,122.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Rickenbach Josef VonCEOSell50,000$49.70$2,485,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Christopher LindopDirectorSell10,000$49.00$490,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Douglas BattSVPSell8,000$48.58$388,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Mark GoldbergCOOSell13,529$48.70$658,862.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Mark GoldbergCOOSell6,957$48.90$340,197.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Mark GoldbergCOOSell6,901$46.49$320,827.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Xavier FlinoisInsiderBuy5,000$41.11$205,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Patrick FortuneDirectorSell7,000$48.31$338,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Richard LoveDirectorSell5,000$47.04$235,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Douglas A BattSVPSell15,000$45.15$677,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Mark A GoldbergCOOSell15,000$45.06$675,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Richard L LoveDirectorSell8,000$46.65$373,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013A Dana Callow JrDirectorSell8,000$46.39$371,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Mark A GoldbergCOOSell28,887$45.19$1,305,403.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Anita CooperVPSell10,000$44.99$449,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Ulf I SchneiderSVPSell20,510$44.54$913,515.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/4/2012Mark A GoldbergCOOSell5,000$32.00$160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for PAREXEL International (NASDAQ:PRXL)
DateHeadline
06/28/16 10:47 AMShare Update and Earnings Review for PAREXEL International Corporation (NASDAQ:PRXL) - Press Telegraph
06/28/16 10:47 AMCredit Suisse Initiates Coverage on PAREXEL International Corporation to Outperform - Trade Calls
06/28/16 10:47 AMShares in Decline this Year PAREXEL International Corporation (NASDAQ:PRXL) - Press Telegraph
06/26/16 10:25 AMStock Performance Focus on: PAREXEL International Corporation (NASDAQ:PRXL) - Press Telegraph
06/26/16 10:25 AMStrong Sell Calls Recommendations For PAREXEL International Corporation (NASDAQ:PRXL) At 1 - Investor Newswire
06/23/16 06:32 PMRecently Issued Stock Ratings For PAREXEL International Corporation (NASDAQ:PRXL) - Fiscal Standard
06/23/16 08:38 AMParexel International (NASDAQ:PRXL) stock price target increased to $75 as announced today by Credit Suisse
06/22/16 05:55 PMParexel International (NASDAQ:PRXL) stock price target increased to $75 as announced today by Credit Suisse - Breaking Finance News
06/21/16 05:30 PMPAREXEL International Corporation Stock Momentum Hits Extreme Weakness - CML News
06/21/16 10:19 AMAvondale Partners Maintains Rating And Lowers Price Target On PAREXEL International Corporati (PRXL)
06/21/16 04:43 AMCoverage initiated on PAREXEL by Credit Suisse -
06/20/16 08:00 AMPAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016 - [Business Wire] - PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association meeting, held from June 26-30, 2016 in Philadelphia.
06/20/16 07:31 AMThis Weeks Broker Views For PAREXEL International Corporation (NASDAQ:PRXL) - Fiscal Standard
06/15/16 10:30 AMPAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30 - Business Wire (press release)
06/15/16 08:00 AMPAREXEL Invites Public to Listen to Live Webcast of Investor Day Presentations on June 30 - [Business Wire] - PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from 9:00 a.m.
06/14/16 05:43 PMPAREXEL International Corporati (NASDAQ:PRXL) Trading Down - Insiders Selling, Short Interest Growing - Finance Daily
06/11/16 06:08 PMWill PAREXEL International Corporation (NASDAQ:PRXL) Surprise This Quarter? - Investor Newswire
06/10/16 01:00 AMPAREXEL Announces Master Services Agreement with Pfizer - [Business Wire] - PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio.
06/09/16 06:21 PMPAREXEL International Corporation (NASDAQ:PRXL) Fundamental Star Rating Report - CML News
06/06/16 05:53 PMPAREXEL International Corporation (NASDAQ:PRXL) Analyst Rating in Focus - Investor Newswire
06/06/16 05:53 PMPAREXEL INTERNATIONAL CORPORATION (NASDAQ:PRXL) Financial Condition Compared to S&P 500 - CML News
06/06/16 09:40 AMPAREXEL International Corporation (NASDAQ:PRXL) Broker Price Targets For The Coming Week - Share Trading News
06/04/16 05:58 PMPerformance Review for PAREXEL International Corporation (NASDAQ:PRXL) - HNN
06/03/16 08:50 AMShare Rating Focus on PAREXEL International Corporation (NASDAQ:PRXL) - HNN - Share Rating Focus on PAREXEL International Corporation (NASDAQ:PRXL)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 2.08 on shares of PAREXEL International Corporation (NASDAQ:PRXL). Covering ...and more »
06/02/16 06:22 PMPAREXEL International Corporation (NASDAQ:PRXL) Set To Release Quarterly Earnings - Investor Newswire - PAREXEL International Corporation (NASDAQ:PRXL) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, PAREXEL International Corporation (NASDAQ:PRXL) is projected to report earnings of $1.05 for its recent quarter. The company plans to release its quarterly report on or around ...and more »
06/02/16 06:22 PMPRXL Crosses Above Key Moving Average Level - Nasdaq - NasdaqPRXL Crosses Above Key Moving Average LevelNasdaqIn trading on Thursday, shares of PAREXEL International Corp. (Symbol: PRXL) crossed above their 200 day moving average of $63.99, changing hands as high as $64.07 per share. PAREXEL International Corp. shares are currently trading up about 1.2% ...Parexel International Corp's (NASDAQ:PRXL) Sentiment is 0.98HNNInsiders are Slowly Decreasing Positions in PAREXEL International Corporation (NASDAQ:PRXL)The PostWhich way PAREXEL International Corporation (NASDAQ:PRXL) earnings may goiStreetWireall 6 news articles »
06/02/16 08:58 AMTarget Price and Stock Performance Rundown for PAREXEL International Corporation (NASDAQ:PRXL) - HNN - Target Price and Stock Performance Rundown for PAREXEL International Corporation (NASDAQ:PRXL)HNNDuring the latest trading session, PAREXEL International Corporation (NASDAQ:PRXL) shares traded +0.65%. Monitoring the stock ... According to Thomson Reuters, analysts are projecting a consensus target price of $68.68 on company stock. Wall Street ...and more »
06/02/16 08:58 AMPAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American ... - Business Wire (press release) - PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American ...Business Wire (press release)BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business AwardsSM.and more »
06/02/16 08:00 AMPAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from the American Business Awards - [Business Wire] - PAREXEL International Corporation , a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business AwardsSM.
05/31/16 06:15 PMPAREXEL International Corporation (NASDAQ:PRXL) Stock Update & Estimates - Stock Tick Tock - PAREXEL International Corporation (NASDAQ:PRXL) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting PAREXEL International Corporation (NASDAQ:PRXL) to post earnings of $0.92 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely ...and more »
05/31/16 06:15 PMStock Paining Investors: PAREXEL International Corporation (NASDAQ:PRXL) - HNN - Stock Paining Investors: PAREXEL International Corporation (NASDAQ:PRXL)HNNWhen a company shows a steady upwards earnings trend, it is a good indicator that the company will dominate companies with a more volatile earnings trend. PAREXEL International Corporation (NASDAQ:PRXL)'s trailing 12 months EPS is 2.68. Last year ...and more »
05/30/16 07:34 PMStrs Ohio Decreased Stake in Chevron Corp. (NYSE:CVX) by $13.64 Million as Shares Rose - CCH Daily News - Strs Ohio Decreased Stake in Chevron Corp. (NYSE:CVX) by $13.64 Million as Shares RoseCCH Daily NewsStrs Ohio, which manages about $22.26 billion US Long portfolio, upped its stake in J C Penney Inc (NYSE:JCP) by 577,900 shares to 3.53 million shares, valued at $38.99M in 2016Q1, according to the filing. It also increased its holding in Parexel Int'l ...and more »
05/24/16 11:47 PMPAREXEL International Corporation (NASDAQ:PRXL) Closes At $59.45 - RealistInvestor.com - PAREXEL International Corporation (NASDAQ:PRXL) Closes At $59.45RealistInvestor.comPAREXEL International Corporation (NASDAQ:PRXL), a NMS public traded company has 51872000 shares floating. Its outstanding shares count is 52887000 bringing market capitalization to $3.24B. In the last session, PAREXEL International Corporation ...PAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare ...Business Wire (press release)PAREXEL International Corporation (NASDAQ:PRXL) Updated Analyst CoverageRisers & FallersParexel International Corp (PRXL) Files Form 4 Insider Selling : Ulf I Schneider Sells 6000 SharesMarket DigestFranklin Independent -Finance Dailyall 8 news articles »
05/24/16 11:17 AMPAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare ... - Business Wire (press release) - PAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare ...Business Wire (press release)BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June ...Parexel International Corp (PRXL) Files Form 4 Insider Selling : Ulf I Schneider Sells 8000 SharesMarket DigestUlf Schneider, SVP & Chief Admin. Officer of PAREXEL International Corporation (NASDAQ:PRXL) Just Sold SharesFranklin IndependentInsiders Selling, Short Interest Growing PAREXEL International Corporati (NASDAQ:PRXL)Finance Dailyall 4 news articles »
05/24/16 08:00 AMPAREXEL International to Present at Goldman Sachs Global Healthcare Conference and Jefferies Healthcare Conference - [Business Wire] - PAREXEL International Corporation announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.
05/23/16 10:04 PMStock Paining Investors: PAREXEL International Corporation (NASDAQ:PRXL) - Wall Street Hints and News - Stock Paining Investors: PAREXEL International Corporation (NASDAQ:PRXL)Wall Street Hints and NewsWhen a company shows a steady upwards earnings trend, it is a good indicator that the company will dominate companies with a more volatile earnings trend. PAREXEL International Corporation (NASDAQ:PRXL)'s trailing 12 months EPS is 2.68. Last year ...and more »
05/22/16 07:14 PMPerformance at a Glance on PAREXEL International Corporation (NASDAQ:PRXL) - Wall Street Hints and News - Performance at a Glance on PAREXEL International Corporation (NASDAQ:PRXL)Wall Street Hints and NewsIt acts as an indicator of a company's profitability. EPS is considered to be the single most important variable in determining a the price of a share. PAREXEL International Corporation (NASDAQ:PRXL)'s EPS growth this year is 17.90% and their trailing ...and more »
05/22/16 12:26 PMParexel Receives a Hold from KeyBanc - Markets.co - Parexel Receives a Hold from KeyBancMarkets.coMost recently, in March 2016, Christopher Lindop, a a Director at PRXL sold 2,000 shares for a total of $120,560. PAREXEL International Corp. is a biopharmaceutical services company. It provides clinical research, medical communications, consulting, ...and more »
05/21/16 07:09 PMPAREXEL International Corporation (NASDAQ:PRXL) Reports Basic Consolidated EPS At $2.6918 - Investor Newswire - PAREXEL International Corporation (NASDAQ:PRXL) Reports Basic Consolidated EPS At $2.6918Investor NewswireFrom the parent firm, PAREXEL International Corporation (NASDAQ:PRXL) diluted EPS came at $2.6473 for the year ended 2015-06-30. For the quarter ended 2015-06-30 it came at $2.6473. PAREXEL International Corporation (NASDAQ:PRXL) posted net ...Parexel International Corporation (NASDAQ:PRXL) Sellers Increased By 2.57% Their ShortsWall Street Hints and NewsLatest Analyst Ratings For PAREXEL International Corporation (NASDAQ:PRXL)Share Trading Newsall 3 news articles »
05/21/16 10:43 AMParexel International Corporation (NASDAQ:PRXL) Sellers Increased By 2.57% Their Shorts - Wall Street Hints and News - Parexel International Corporation (NASDAQ:PRXL) Sellers Increased By 2.57% Their ShortsWall Street Hints and NewsPAREXEL International Corporation is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology services ...Latest Analyst Ratings For PAREXEL International Corporation (NASDAQ:PRXL)Share Trading Newsall 2 news articles »
05/18/16 09:57 PMTop Earnings to Watch for: PAREXEL International Corporation (NASDAQ:PRXL) - PAREXEL International Corporation (PRXL) retreated -1.14% to reach at the floor price of $58.3 as the company is set to share its next quarterly earnings on August 03, 2016. PRXL stock trades between $58 and $59.91 before the earnings release. Let’s take ...
05/16/16 01:13 PMAberdeen Asset Management Plc Increased Parexel Intl Corp (NASDAQ:PRXL) by $15.67 Million as Shares Declined - Wall Street Hints and News - Aberdeen Asset Management Plc Increased Parexel Intl Corp (NASDAQ:PRXL) by $15.67 Million as Shares DeclinedWall Street Hints and NewsPAREXEL International Corporation is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology services ...and more »
05/09/16 08:00 AMPAREXEL International to Present at UBS Healthcare Conference - [Business Wire] - PAREXEL International Corporation announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City. Ingo Bank, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL and discussing business developments at 8:30 a.m.
05/07/16 12:04 PMPAREXEL INTERNATIONAL CORP Financials -
05/02/16 04:23 PMETF’s with exposure to PAREXEL International Corp. : May 2, 2016 -
04/29/16 08:43 AMPAREXEL International Corp. :PRXL-US: Earnings Analysis: Q3, 2016 By the Numbers -
04/29/16 07:40 AMPAREXEL International Corp. breached its 50 day moving average in a Bearish Manner : PRXL-US : April 29, 2016 -
04/28/16 09:00 AMPAREXEL International Corp Earnings Call scheduled for 10:00 am ET today -
04/28/16 08:30 AMThe Zacks Analyst Blog Highlights: Newell Brands, Hormel Foods, Shire and PAREXEL International -
04/27/16 03:19 PMPAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an -
About PAREXEL International

PAREXEL International logoPAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world. The Company operates through three segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics. Its product and service offerings include clinical trials management, data management, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, medical imaging services, electronic data capture systems, clinical trial management systems, Web-based portals, and other product development tools and services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: PRXL
  • CUSIP: 69946210
Key Metrics:
  • Previous Close: $59.50
  • 50 Day Moving Average: $60.15
  • 200 Day Moving Average: $62.20
  • P/E Ratio: 22.62
  • P/E Growth: 1.02
  • Market Cap: $3.19B
  • Current Quarter EPS Consensus Estimate: $3.42 EPS
Additional Links:
PAREXEL International (NASDAQ:PRXL) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha